These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 1825816
21. Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis. Ju G, Labriola-Tompkins E, Campen CA, Benjamin WR, Karas J, Plocinski J, Biondi D, Kaffka KL, Kilian PL, Eisenberg SP. Proc Natl Acad Sci U S A; 1991 Apr 01; 88(7):2658-62. PubMed ID: 1826365 [Abstract] [Full Text] [Related]
23. Neutrophil accumulation and activation by homologous IL-8 in rabbits. IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo. Matsukawa A, Yoshimura T, Maeda T, Ohkawara S, Takagi K, Yoshinaga M. J Immunol; 1995 May 15; 154(10):5418-25. PubMed ID: 7730643 [Abstract] [Full Text] [Related]
24. Lipopolysaccharide, tumor necrosis factor, and interleukin-1 interact to cause hypotension. Weinberg JR, Boyle P, Meager A, Guz A. J Lab Clin Med; 1992 Aug 15; 120(2):205-11. PubMed ID: 1500820 [Abstract] [Full Text] [Related]
25. The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation. Ulich TR, Yin SM, Guo KZ, del Castillo J, Eisenberg SP, Thompson RC. Am J Pathol; 1991 Mar 15; 138(3):521-4. PubMed ID: 1825745 [Abstract] [Full Text] [Related]
31. Evaluation of interleukin-1 receptor antagonist (IL-1RA) and tumor necrosis factor binding protein (TNF-BP) in a rodent abscess model of host resistance. Colagiovanni DB, Shopp GM. Immunopharmacol Immunotoxicol; 1996 Aug 15; 18(3):397-419. PubMed ID: 8872492 [Abstract] [Full Text] [Related]
33. IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils. Marie C, Pitton C, Fitting C, Cavaillon JM. Cytokine; 1996 Feb 15; 8(2):147-51. PubMed ID: 8777273 [Abstract] [Full Text] [Related]
37. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Vannier E, Miller LC, Dinarello CA. Proc Natl Acad Sci U S A; 1992 May 01; 89(9):4076-80. PubMed ID: 1533284 [Abstract] [Full Text] [Related]
38. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis. Matsukawa A, Yoshimura T, Maeda T, Takahashi T, Ohkawara S, Yoshinaga M. Lab Invest; 1998 May 01; 78(5):559-69. PubMed ID: 9605181 [Abstract] [Full Text] [Related]
39. Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis. Porat R, Paddock HN, Schwaitzberg SD, Connolly RJ, Wilkens T, Dasch JR, Gascon MP, Hutchison JS, Ythier A, Wallach D. Crit Care Med; 1995 Jun 01; 23(6):1080-9. PubMed ID: 7774220 [Abstract] [Full Text] [Related]
40. Interleukin-1 mediates hemodynamic dysfunction and release of eicosanoids and tumor necrosis factor during graded bacteremia. Santos MC, Woolley DS, Quinn JV, Slotman GJ. Shock; 1999 Jun 01; 11(6):423-8. PubMed ID: 10454832 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]